More than 30 million people globally living with HIV currently rely on daily antiretroviral therapy (ART) to manage the virus, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). But what if that daily burden could be lifted? Researchers are now exploring a novel approach—enhancing the body’s own immune cells—that could offer long-term control of HIV without lifelong medication.
- Scientists at Case Western Reserve University and the University of Pittsburgh have successfully enhanced natural killer (NK) cells to better target HIV.
- The enhanced NK cells demonstrate an ability to reduce the viral reservoirs where HIV hides within the body.
- Researchers aim to begin clinical trials within the next two years to test this approach in people living with HIV.
- This immunotherapy builds on existing cancer treatments utilizing NK cells, offering a promising path toward a functional HIV cure.
Q: Could NK cell therapy eventually eliminate the need for daily HIV medication? A: Researchers are hopeful that this approach will reduce the viral reservoir enough to allow for long-term immunological control of HIV, potentially freeing individuals from a lifetime of antiretroviral therapy.
Boosting the Body’s Natural Defenses Against HIV
Scientists at Case Western Reserve University, working in collaboration with the University of Pittsburgh, have achieved a significant breakthrough in HIV research. Their work focuses on natural killer (NK) cells—specialized immune cells naturally equipped to identify and destroy virus-infected and cancerous cells—and how to make them even more effective against HIV.
“NK cell immunotherapy is already being used for cancer therapy, and the data from those studies provide a great foundation for translation of this approach to an HIV cure strategy,” explained Mary Ann Checkley-Luttge, Senior Research Associate at the Case Western Reserve School of Medicine, who spearheaded the study. “We are hoping that NK cell immunotherapy can help reduce the reservoir enough to allow long-term immunological control of HIV without ART.”
The team discovered that NK cells extracted from individuals living with HIV can be expanded and strengthened in a laboratory setting. These enhanced NK cells demonstrate a heightened ability to locate and diminish the virus lurking within the body’s reservoirs—those hidden pockets where HIV remains dormant, capable of reactivating if treatment is stopped. This represents a crucial step toward achieving long-term HIV remission by leveraging the power of the immune system.
A Legacy of HIV Research
Case Western Reserve University boasts a decades-long commitment to interdisciplinary HIV research. Its School of Medicine is home to a National Institutes of Health-designated Center for AIDS Research, established over 30 years ago, and the Center for Excellence on the Impact of Substance Use on HIV. These resources provide researchers with access to cutting-edge technologies vital for groundbreaking studies.
“Our team’s next goals are to test whether lab-enhanced NK cells can work as ‘off-the-shelf’ therapy,” stated Jonathon Karn, Distinguished University Professor and Chair of the Department of Molecular Biology and Microbiology. “We plan to conduct studies using advanced animal models that closely mimic HIV infection in humans and then work toward clinical trials in the next two years to test this approach in people living with HIV.”
The success of this research is rooted in a collaborative spirit, fueled by blood donations from people living with HIV and the dedication of researchers and institutions united in their pursuit of improved HIV treatments. By combining patient participation with innovative science, the team hopes to usher in a new era of therapies that could dramatically improve the lives of millions affected by HIV.
